NCT00371215View on ClinicalTrials.gov

Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting

PHASE2CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions

Surgical Hemostasis

Interventions

BIOLOGICAL

rThrombin

1000 U/mL applied topically

Trial Locations (1)

46202

Richard M. Fairbanks Burn Center, Wishard Hospital, Indianapolis

Sponsors

Lead Sponsor

All Listed Sponsors

lead

ZymoGenetics

INDUSTRY

NCT00371215 - Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting | Biotech Hunter | Biotech Hunter